Summer 2022 Vol. 12 Issue 02
-
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug TargetNew therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
Marking Cancer MilestonesFind unique ways to honor significant dates as you move forward after cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Learning Your LimitsAs a caregiver, you want to be there for your loved ones, but it's also necessary to take time for yourself.
by K.J. Bannan
-
Policy Matters
A Groundbreaking Report on COVID-19 and CancerThe report released by the American Association for Cancer Research includes a Call to Action that offers a roadmap for policymakers to better prepare and respond to the next pandemic.
by Antoni Ribas, MD, PhD
-
The Pain of GriefPeople affected by cancer often experience intense feelings of loss when those around them die of the disease.
by Charlotte Huff
-
Comorbidity: Treating the Whole PatientPatients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
Disparities in Cervical CancerMany women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
by Natalie Slivinski
-
Survivor Profile
Control What You CanBusiness leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
-
-
Q&A
Show Me You CareTheresa Brown, who was a nurse when she was diagnosed with breast cancer, writes about deep gaps in her own care.
by Marci A. Landsmann
-
-
Get Involved
Blankets of SupportTeenage cancer survivor provides comfort to children with cancer.
by Thomas Celona
-
Facts and Stats
Driving Down Lung Cancer DeathsScreenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
by Eric Fitzsimmons
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
